Document is current
Any future updates will be listed below
-
Authors
Fantaguzzi, Federico
Servillo, Andrea
Sacconi, Riccardo
Tombolini, Beatrice
Bandello, Francesco
Querques, Giuseppe https://orcid.org/0000-0002-3292-9581
- License Information
-
More Information
Article History
Received: 22 June 2022
Revised: 20 October 2022
Accepted: 22 November 2022
First Online: 2 December 2022
Declarations
:
: This study was approved by our local ethical committee (IRCCS Ospedale San Raffaele). Written consent to participate in the study was obtained by all participants.
: FF has nothing to disclose. AS has nothing to disclose. RS serves as a consultant for Allergan, Bayer, Novartis, and Zeiss. BT has nothing to disclose. FB serves as consultant for Allergan, Bayer, Boehringer-Ingelheim, Fidia Sooft, Hofmann La Roche, Novartis, Ntc Pharma, Sifi, Thrombogenics, and Zeiss. GQ serves as consultant for Alimera Sciences, Allergan Inc, Amgen, Heidelberg, KBH, LEH Pharma, Lumithera, Novartis, Bayer Shering-Pharma, Sandoz, Sifi, Soof-Fidia, and Zeiss.
: This study involves human participants. All procedures performed in studies involving human participants were in accordance with the ethical standards of the local ethical committee (IRCCS Ospedale San Raffaele) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: None. All authors attest that they meet the current ICMJE criteria for authorship.
